Dupilumab Compassionate Use Study
NCT03020810
·
clinicaltrials.gov ↗
APPROVED_FOR_MARKETING
Status
OTHER
Sponsor class
Conditions
Asthma
Interventions
DRUG:
Dupilumab
Sponsor
Sally E. Wenzel MD